The novel therapy of the medication represents a exciting development in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide501055.blogpixi.com/42359568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment